XML 27 R77.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidating Financial Statements (Condensed Consolidating Statement of Cash Flows) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Operating Activities    
Net income (loss) $ 16,732 $ 20,692
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 2,961 3,268
Deferred income taxes 7,140 6,797
Amortization of deferred financing costs 851 892
Stock-based compensation costs 1,858 1,193
Amortization of debt discount 144 345
Gain on sale of assets 0 (2)
Equity in income of subsidiaries 0 0
Changes in operating assets and liabilities, net of effects from acquisitions    
Accounts receivable 6,956 11,070
Inventories 1,540 (6,716)
Prepaid expenses and other current assets (2,203) 187
Accounts payable (3,096) (9,147)
Accrued liabilities (3,212) (5,781)
Net cash provided by (used in) operating activities 29,671 22,798
Investing Activities    
Purchases of property and equipment (496) (1,364)
Net book value of property and equipment transferred 0 2
Acquisition of the Hydralyte brand (77,991) 0
Intercompany activity, net 0  
Net cash used in investing activities (78,487) (1,362)
Financing Activities    
Repayments under revolving credit agreement (30,000) (18,000)
Borrowings under revolving credit agreement 65,000 0
Payment of deferred financing costs (74) (280)
Proceeds from exercise of stock options 1,294 309
Proceeds from restricted stock exercises 57 0
Excess tax benefits from share-based awards 950 452
Shares surrendered as payment of tax withholding (1,171) (278)
Intercompany activity, net 0 0
Net cash provided by (used in) financing activities 36,056 (17,797)
Effects of exchange rate changes on cash and cash equivalents 104 (3)
(Decrease) increase in cash and cash equivalents (12,656) 3,636
Cash and cash equivalents - beginning of period 28,331 15,670
Cash and cash equivalents - end of period 15,675 19,306
Prestige Brands Holdings, Inc.
   
Operating Activities    
Net income (loss) 16,732 20,692
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 642 517
Deferred income taxes (1) (21)
Amortization of deferred financing costs    0
Stock-based compensation costs 1,858 1,193
Amortization of debt discount    0
Gain on sale of assets   0
Equity in income of subsidiaries (15,679) (19,855)
Changes in operating assets and liabilities, net of effects from acquisitions    
Accounts receivable 467 (122)
Inventories 0 0
Prepaid expenses and other current assets 947 2,100
Accounts payable (936) (417)
Accrued liabilities (4,800) (5,468)
Net cash provided by (used in) operating activities (770) (1,381)
Investing Activities    
Purchases of property and equipment (385) (1,364)
Net book value of property and equipment transferred   0
Acquisition of the Hydralyte brand 0  
Intercompany activity, net     
Net cash used in investing activities (385) (1,364)
Financing Activities    
Repayments under revolving credit agreement 0 0
Borrowings under revolving credit agreement 0  
Payment of deferred financing costs 0 0
Proceeds from exercise of stock options 1,294 309
Proceeds from restricted stock exercises 57  
Excess tax benefits from share-based awards 950 452
Shares surrendered as payment of tax withholding (1,171) (278)
Intercompany activity, net (13,700) 5,867
Net cash provided by (used in) financing activities (12,570) 6,350
Effects of exchange rate changes on cash and cash equivalents 0 0
(Decrease) increase in cash and cash equivalents (13,725) 3,605
Cash and cash equivalents - beginning of period 24,644 14,720
Cash and cash equivalents - end of period 10,919 18,325
Prestige Brands, Inc., the issuer
   
Operating Activities    
Net income (loss) 17,506 19,525
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 145 142
Deferred income taxes 892 529
Amortization of deferred financing costs 851 892
Stock-based compensation costs    0
Amortization of debt discount 144 345
Gain on sale of assets   0
Equity in income of subsidiaries (10,898) (14,553)
Changes in operating assets and liabilities, net of effects from acquisitions    
Accounts receivable (130) 2,362
Inventories 3,288 (623)
Prepaid expenses and other current assets (920) (630)
Accounts payable (916) (2,960)
Accrued liabilities 4,733 246
Net cash provided by (used in) operating activities 14,695 5,275
Investing Activities    
Purchases of property and equipment    0
Net book value of property and equipment transferred   0
Acquisition of the Hydralyte brand 0  
Intercompany activity, net (77,991)  
Net cash used in investing activities (77,991) 0
Financing Activities    
Repayments under revolving credit agreement (30,000) (18,000)
Borrowings under revolving credit agreement 65,000  
Payment of deferred financing costs (74) (280)
Proceeds from exercise of stock options 0 0
Proceeds from restricted stock exercises 0  
Excess tax benefits from share-based awards 0 0
Shares surrendered as payment of tax withholding 0 0
Intercompany activity, net 28,370 13,005
Net cash provided by (used in) financing activities 63,296 (5,275)
Effects of exchange rate changes on cash and cash equivalents 0 0
(Decrease) increase in cash and cash equivalents 0 0
Cash and cash equivalents - beginning of period 0 0
Cash and cash equivalents - end of period 0 0
Combined Subsidiary Guarantors
   
Operating Activities    
Net income (loss) 10,109 14,883
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 2,089 2,595
Deferred income taxes 6,330 6,291
Amortization of deferred financing costs    0
Stock-based compensation costs    0
Amortization of debt discount    0
Gain on sale of assets   (2)
Equity in income of subsidiaries 959 (679)
Changes in operating assets and liabilities, net of effects from acquisitions    
Accounts receivable 8,941 9,125
Inventories (2,822) (6,142)
Prepaid expenses and other current assets (1,706) (1,269)
Accounts payable (2,918) (6,178)
Accrued liabilities (5,663) (741)
Net cash provided by (used in) operating activities 15,319 17,883
Investing Activities    
Purchases of property and equipment (11) 0
Net book value of property and equipment transferred   2
Acquisition of the Hydralyte brand 0  
Intercompany activity, net     
Net cash used in investing activities (11) 2
Financing Activities    
Repayments under revolving credit agreement 0 0
Borrowings under revolving credit agreement 0  
Payment of deferred financing costs 0 0
Proceeds from exercise of stock options 0 0
Proceeds from restricted stock exercises 0  
Excess tax benefits from share-based awards 0 0
Shares surrendered as payment of tax withholding 0 0
Intercompany activity, net (15,308) (17,885)
Net cash provided by (used in) financing activities (15,308) (17,885)
Effects of exchange rate changes on cash and cash equivalents 0 0
(Decrease) increase in cash and cash equivalents 0 0
Cash and cash equivalents - beginning of period 0 0
Cash and cash equivalents - end of period 0 0
Combined Non-Guarantor Subsidiaries
   
Operating Activities    
Net income (loss) (959) 679
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 85 14
Deferred income taxes (81) (2)
Amortization of deferred financing costs    0
Stock-based compensation costs    0
Amortization of debt discount    0
Gain on sale of assets   0
Equity in income of subsidiaries 0 0
Changes in operating assets and liabilities, net of effects from acquisitions    
Accounts receivable (2,322) (295)
Inventories 36 49
Prepaid expenses and other current assets (524) (14)
Accounts payable 1,674 408
Accrued liabilities 2,518 182
Net cash provided by (used in) operating activities 427 1,021
Investing Activities    
Purchases of property and equipment (100) 0
Net book value of property and equipment transferred   0
Acquisition of the Hydralyte brand (77,991)  
Intercompany activity, net 77,991  
Net cash used in investing activities (100) 0
Financing Activities    
Repayments under revolving credit agreement 0 0
Borrowings under revolving credit agreement 0  
Payment of deferred financing costs 0 0
Proceeds from exercise of stock options 0 0
Proceeds from restricted stock exercises 0  
Excess tax benefits from share-based awards 0 0
Shares surrendered as payment of tax withholding 0 0
Intercompany activity, net 638 (987)
Net cash provided by (used in) financing activities 638 (987)
Effects of exchange rate changes on cash and cash equivalents 104 (3)
(Decrease) increase in cash and cash equivalents 1,069 31
Cash and cash equivalents - beginning of period 3,687 950
Cash and cash equivalents - end of period 4,756 981
Eliminations
   
Operating Activities    
Net income (loss) (26,656) (35,087)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 0 0
Deferred income taxes 0 0
Amortization of deferred financing costs    0
Stock-based compensation costs    0
Amortization of debt discount    0
Gain on sale of assets   0
Equity in income of subsidiaries 25,618 35,087
Changes in operating assets and liabilities, net of effects from acquisitions    
Accounts receivable 0 0
Inventories 1,038 0
Prepaid expenses and other current assets 0 0
Accounts payable 0 0
Accrued liabilities 0 0
Net cash provided by (used in) operating activities 0 0
Investing Activities    
Purchases of property and equipment    0
Net book value of property and equipment transferred   0
Acquisition of the Hydralyte brand 0  
Intercompany activity, net     
Net cash used in investing activities 0 0
Financing Activities    
Repayments under revolving credit agreement 0 0
Borrowings under revolving credit agreement 0  
Payment of deferred financing costs 0 0
Proceeds from exercise of stock options 0 0
Proceeds from restricted stock exercises 0  
Excess tax benefits from share-based awards 0 0
Shares surrendered as payment of tax withholding 0 0
Intercompany activity, net 0 0
Net cash provided by (used in) financing activities 0 0
Effects of exchange rate changes on cash and cash equivalents 0 0
(Decrease) increase in cash and cash equivalents 0 0
Cash and cash equivalents - beginning of period 0 0
Cash and cash equivalents - end of period $ 0 $ 0